Global Pediatric Psoriasis Supply, Demand and Key Producers, 2023-2029
The global Pediatric Psoriasis market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Pediatric Psoriasis demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pediatric Psoriasis, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pediatric Psoriasis that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pediatric Psoriasis total market, 2018-2029, (USD Million)
Global Pediatric Psoriasis total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Pediatric Psoriasis total market, key domestic companies and share, (USD Million)
Global Pediatric Psoriasis revenue by player and market share 2018-2023, (USD Million)
Global Pediatric Psoriasis total market by Type, CAGR, 2018-2029, (USD Million)
Global Pediatric Psoriasis total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Pediatric Psoriasis market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbvie Inc, Amgen Inc, Johnson & Johnson, Novartis Ag, Eli Lilly & Company, Astrazeneca, Celgene Corporation, Merck and Boehringer Ingelheim, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pediatric Psoriasis market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Pediatric Psoriasis Market, By Region:
1. How big is the global Pediatric Psoriasis market?
2. What is the demand of the global Pediatric Psoriasis market?
3. What is the year over year growth of the global Pediatric Psoriasis market?
4. What is the total value of the global Pediatric Psoriasis market?
5. Who are the major players in the global Pediatric Psoriasis market?
6. What are the growth factors driving the market demand?
This report studies the global Pediatric Psoriasis demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pediatric Psoriasis, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pediatric Psoriasis that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pediatric Psoriasis total market, 2018-2029, (USD Million)
Global Pediatric Psoriasis total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Pediatric Psoriasis total market, key domestic companies and share, (USD Million)
Global Pediatric Psoriasis revenue by player and market share 2018-2023, (USD Million)
Global Pediatric Psoriasis total market by Type, CAGR, 2018-2029, (USD Million)
Global Pediatric Psoriasis total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Pediatric Psoriasis market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbvie Inc, Amgen Inc, Johnson & Johnson, Novartis Ag, Eli Lilly & Company, Astrazeneca, Celgene Corporation, Merck and Boehringer Ingelheim, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pediatric Psoriasis market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Pediatric Psoriasis Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Oral
- Injection
- Others
- Hospital
- Clinic
- Others
- Abbvie Inc
- Amgen Inc
- Johnson & Johnson
- Novartis Ag
- Eli Lilly & Company
- Astrazeneca
- Celgene Corporation
- Merck
- Boehringer Ingelheim
- Leo Pharma
1. How big is the global Pediatric Psoriasis market?
2. What is the demand of the global Pediatric Psoriasis market?
3. What is the year over year growth of the global Pediatric Psoriasis market?
4. What is the total value of the global Pediatric Psoriasis market?
5. Who are the major players in the global Pediatric Psoriasis market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Pediatric Psoriasis Introduction
1.2 World Pediatric Psoriasis Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Pediatric Psoriasis Total Market by Region (by Headquarter Location)
1.3.1 World Pediatric Psoriasis Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Pediatric Psoriasis Market Size (2018-2029)
1.3.3 China Pediatric Psoriasis Market Size (2018-2029)
1.3.4 Europe Pediatric Psoriasis Market Size (2018-2029)
1.3.5 Japan Pediatric Psoriasis Market Size (2018-2029)
1.3.6 South Korea Pediatric Psoriasis Market Size (2018-2029)
1.3.7 ASEAN Pediatric Psoriasis Market Size (2018-2029)
1.3.8 India Pediatric Psoriasis Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pediatric Psoriasis Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pediatric Psoriasis Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Pediatric Psoriasis Consumption Value (2018-2029)
2.2 World Pediatric Psoriasis Consumption Value by Region
2.2.1 World Pediatric Psoriasis Consumption Value by Region (2018-2023)
2.2.2 World Pediatric Psoriasis Consumption Value Forecast by Region (2024-2029)
2.3 United States Pediatric Psoriasis Consumption Value (2018-2029)
2.4 China Pediatric Psoriasis Consumption Value (2018-2029)
2.5 Europe Pediatric Psoriasis Consumption Value (2018-2029)
2.6 Japan Pediatric Psoriasis Consumption Value (2018-2029)
2.7 South Korea Pediatric Psoriasis Consumption Value (2018-2029)
2.8 ASEAN Pediatric Psoriasis Consumption Value (2018-2029)
2.9 India Pediatric Psoriasis Consumption Value (2018-2029)
3 WORLD PEDIATRIC PSORIASIS COMPANIES COMPETITIVE ANALYSIS
3.1 World Pediatric Psoriasis Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Pediatric Psoriasis Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Pediatric Psoriasis in 2022
3.2.3 Global Concentration Ratios (CR8) for Pediatric Psoriasis in 2022
3.3 Pediatric Psoriasis Company Evaluation Quadrant
3.4 Pediatric Psoriasis Market: Overall Company Footprint Analysis
3.4.1 Pediatric Psoriasis Market: Region Footprint
3.4.2 Pediatric Psoriasis Market: Company Product Type Footprint
3.4.3 Pediatric Psoriasis Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Pediatric Psoriasis Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Pediatric Psoriasis Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Pediatric Psoriasis Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Pediatric Psoriasis Consumption Value Comparison
4.2.1 United States VS China: Pediatric Psoriasis Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Pediatric Psoriasis Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Pediatric Psoriasis Companies and Market Share, 2018-2023
4.3.1 United States Based Pediatric Psoriasis Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Pediatric Psoriasis Revenue, (2018-2023)
4.4 China Based Companies Pediatric Psoriasis Revenue and Market Share, 2018-2023
4.4.1 China Based Pediatric Psoriasis Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Pediatric Psoriasis Revenue, (2018-2023)
4.5 Rest of World Based Pediatric Psoriasis Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Pediatric Psoriasis Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Pediatric Psoriasis Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Pediatric Psoriasis Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Oral
5.2.2 Injection
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Pediatric Psoriasis Market Size by Type (2018-2023)
5.3.2 World Pediatric Psoriasis Market Size by Type (2024-2029)
5.3.3 World Pediatric Psoriasis Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Pediatric Psoriasis Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Pediatric Psoriasis Market Size by Application (2018-2023)
6.3.2 World Pediatric Psoriasis Market Size by Application (2024-2029)
6.3.3 World Pediatric Psoriasis Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Abbvie Inc
7.1.1 Abbvie Inc Details
7.1.2 Abbvie Inc Major Business
7.1.3 Abbvie Inc Pediatric Psoriasis Product and Services
7.1.4 Abbvie Inc Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Abbvie Inc Recent Developments/Updates
7.1.6 Abbvie Inc Competitive Strengths & Weaknesses
7.2 Amgen Inc
7.2.1 Amgen Inc Details
7.2.2 Amgen Inc Major Business
7.2.3 Amgen Inc Pediatric Psoriasis Product and Services
7.2.4 Amgen Inc Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Amgen Inc Recent Developments/Updates
7.2.6 Amgen Inc Competitive Strengths & Weaknesses
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Details
7.3.2 Johnson & Johnson Major Business
7.3.3 Johnson & Johnson Pediatric Psoriasis Product and Services
7.3.4 Johnson & Johnson Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Johnson & Johnson Recent Developments/Updates
7.3.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.4 Novartis Ag
7.4.1 Novartis Ag Details
7.4.2 Novartis Ag Major Business
7.4.3 Novartis Ag Pediatric Psoriasis Product and Services
7.4.4 Novartis Ag Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Novartis Ag Recent Developments/Updates
7.4.6 Novartis Ag Competitive Strengths & Weaknesses
7.5 Eli Lilly & Company
7.5.1 Eli Lilly & Company Details
7.5.2 Eli Lilly & Company Major Business
7.5.3 Eli Lilly & Company Pediatric Psoriasis Product and Services
7.5.4 Eli Lilly & Company Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Eli Lilly & Company Recent Developments/Updates
7.5.6 Eli Lilly & Company Competitive Strengths & Weaknesses
7.6 Astrazeneca
7.6.1 Astrazeneca Details
7.6.2 Astrazeneca Major Business
7.6.3 Astrazeneca Pediatric Psoriasis Product and Services
7.6.4 Astrazeneca Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Astrazeneca Recent Developments/Updates
7.6.6 Astrazeneca Competitive Strengths & Weaknesses
7.7 Celgene Corporation
7.7.1 Celgene Corporation Details
7.7.2 Celgene Corporation Major Business
7.7.3 Celgene Corporation Pediatric Psoriasis Product and Services
7.7.4 Celgene Corporation Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Celgene Corporation Recent Developments/Updates
7.7.6 Celgene Corporation Competitive Strengths & Weaknesses
7.8 Merck
7.8.1 Merck Details
7.8.2 Merck Major Business
7.8.3 Merck Pediatric Psoriasis Product and Services
7.8.4 Merck Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Merck Recent Developments/Updates
7.8.6 Merck Competitive Strengths & Weaknesses
7.9 Boehringer Ingelheim
7.9.1 Boehringer Ingelheim Details
7.9.2 Boehringer Ingelheim Major Business
7.9.3 Boehringer Ingelheim Pediatric Psoriasis Product and Services
7.9.4 Boehringer Ingelheim Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Boehringer Ingelheim Recent Developments/Updates
7.9.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.10 Leo Pharma
7.10.1 Leo Pharma Details
7.10.2 Leo Pharma Major Business
7.10.3 Leo Pharma Pediatric Psoriasis Product and Services
7.10.4 Leo Pharma Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Leo Pharma Recent Developments/Updates
7.10.6 Leo Pharma Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Pediatric Psoriasis Industry Chain
8.2 Pediatric Psoriasis Upstream Analysis
8.3 Pediatric Psoriasis Midstream Analysis
8.4 Pediatric Psoriasis Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Pediatric Psoriasis Introduction
1.2 World Pediatric Psoriasis Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Pediatric Psoriasis Total Market by Region (by Headquarter Location)
1.3.1 World Pediatric Psoriasis Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Pediatric Psoriasis Market Size (2018-2029)
1.3.3 China Pediatric Psoriasis Market Size (2018-2029)
1.3.4 Europe Pediatric Psoriasis Market Size (2018-2029)
1.3.5 Japan Pediatric Psoriasis Market Size (2018-2029)
1.3.6 South Korea Pediatric Psoriasis Market Size (2018-2029)
1.3.7 ASEAN Pediatric Psoriasis Market Size (2018-2029)
1.3.8 India Pediatric Psoriasis Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pediatric Psoriasis Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pediatric Psoriasis Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Pediatric Psoriasis Consumption Value (2018-2029)
2.2 World Pediatric Psoriasis Consumption Value by Region
2.2.1 World Pediatric Psoriasis Consumption Value by Region (2018-2023)
2.2.2 World Pediatric Psoriasis Consumption Value Forecast by Region (2024-2029)
2.3 United States Pediatric Psoriasis Consumption Value (2018-2029)
2.4 China Pediatric Psoriasis Consumption Value (2018-2029)
2.5 Europe Pediatric Psoriasis Consumption Value (2018-2029)
2.6 Japan Pediatric Psoriasis Consumption Value (2018-2029)
2.7 South Korea Pediatric Psoriasis Consumption Value (2018-2029)
2.8 ASEAN Pediatric Psoriasis Consumption Value (2018-2029)
2.9 India Pediatric Psoriasis Consumption Value (2018-2029)
3 WORLD PEDIATRIC PSORIASIS COMPANIES COMPETITIVE ANALYSIS
3.1 World Pediatric Psoriasis Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Pediatric Psoriasis Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Pediatric Psoriasis in 2022
3.2.3 Global Concentration Ratios (CR8) for Pediatric Psoriasis in 2022
3.3 Pediatric Psoriasis Company Evaluation Quadrant
3.4 Pediatric Psoriasis Market: Overall Company Footprint Analysis
3.4.1 Pediatric Psoriasis Market: Region Footprint
3.4.2 Pediatric Psoriasis Market: Company Product Type Footprint
3.4.3 Pediatric Psoriasis Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Pediatric Psoriasis Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Pediatric Psoriasis Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Pediatric Psoriasis Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Pediatric Psoriasis Consumption Value Comparison
4.2.1 United States VS China: Pediatric Psoriasis Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Pediatric Psoriasis Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Pediatric Psoriasis Companies and Market Share, 2018-2023
4.3.1 United States Based Pediatric Psoriasis Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Pediatric Psoriasis Revenue, (2018-2023)
4.4 China Based Companies Pediatric Psoriasis Revenue and Market Share, 2018-2023
4.4.1 China Based Pediatric Psoriasis Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Pediatric Psoriasis Revenue, (2018-2023)
4.5 Rest of World Based Pediatric Psoriasis Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Pediatric Psoriasis Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Pediatric Psoriasis Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Pediatric Psoriasis Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Oral
5.2.2 Injection
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Pediatric Psoriasis Market Size by Type (2018-2023)
5.3.2 World Pediatric Psoriasis Market Size by Type (2024-2029)
5.3.3 World Pediatric Psoriasis Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Pediatric Psoriasis Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Pediatric Psoriasis Market Size by Application (2018-2023)
6.3.2 World Pediatric Psoriasis Market Size by Application (2024-2029)
6.3.3 World Pediatric Psoriasis Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Abbvie Inc
7.1.1 Abbvie Inc Details
7.1.2 Abbvie Inc Major Business
7.1.3 Abbvie Inc Pediatric Psoriasis Product and Services
7.1.4 Abbvie Inc Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Abbvie Inc Recent Developments/Updates
7.1.6 Abbvie Inc Competitive Strengths & Weaknesses
7.2 Amgen Inc
7.2.1 Amgen Inc Details
7.2.2 Amgen Inc Major Business
7.2.3 Amgen Inc Pediatric Psoriasis Product and Services
7.2.4 Amgen Inc Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Amgen Inc Recent Developments/Updates
7.2.6 Amgen Inc Competitive Strengths & Weaknesses
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Details
7.3.2 Johnson & Johnson Major Business
7.3.3 Johnson & Johnson Pediatric Psoriasis Product and Services
7.3.4 Johnson & Johnson Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Johnson & Johnson Recent Developments/Updates
7.3.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.4 Novartis Ag
7.4.1 Novartis Ag Details
7.4.2 Novartis Ag Major Business
7.4.3 Novartis Ag Pediatric Psoriasis Product and Services
7.4.4 Novartis Ag Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Novartis Ag Recent Developments/Updates
7.4.6 Novartis Ag Competitive Strengths & Weaknesses
7.5 Eli Lilly & Company
7.5.1 Eli Lilly & Company Details
7.5.2 Eli Lilly & Company Major Business
7.5.3 Eli Lilly & Company Pediatric Psoriasis Product and Services
7.5.4 Eli Lilly & Company Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Eli Lilly & Company Recent Developments/Updates
7.5.6 Eli Lilly & Company Competitive Strengths & Weaknesses
7.6 Astrazeneca
7.6.1 Astrazeneca Details
7.6.2 Astrazeneca Major Business
7.6.3 Astrazeneca Pediatric Psoriasis Product and Services
7.6.4 Astrazeneca Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Astrazeneca Recent Developments/Updates
7.6.6 Astrazeneca Competitive Strengths & Weaknesses
7.7 Celgene Corporation
7.7.1 Celgene Corporation Details
7.7.2 Celgene Corporation Major Business
7.7.3 Celgene Corporation Pediatric Psoriasis Product and Services
7.7.4 Celgene Corporation Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Celgene Corporation Recent Developments/Updates
7.7.6 Celgene Corporation Competitive Strengths & Weaknesses
7.8 Merck
7.8.1 Merck Details
7.8.2 Merck Major Business
7.8.3 Merck Pediatric Psoriasis Product and Services
7.8.4 Merck Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Merck Recent Developments/Updates
7.8.6 Merck Competitive Strengths & Weaknesses
7.9 Boehringer Ingelheim
7.9.1 Boehringer Ingelheim Details
7.9.2 Boehringer Ingelheim Major Business
7.9.3 Boehringer Ingelheim Pediatric Psoriasis Product and Services
7.9.4 Boehringer Ingelheim Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Boehringer Ingelheim Recent Developments/Updates
7.9.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.10 Leo Pharma
7.10.1 Leo Pharma Details
7.10.2 Leo Pharma Major Business
7.10.3 Leo Pharma Pediatric Psoriasis Product and Services
7.10.4 Leo Pharma Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Leo Pharma Recent Developments/Updates
7.10.6 Leo Pharma Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Pediatric Psoriasis Industry Chain
8.2 Pediatric Psoriasis Upstream Analysis
8.3 Pediatric Psoriasis Midstream Analysis
8.4 Pediatric Psoriasis Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Pediatric Psoriasis Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Pediatric Psoriasis Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Pediatric Psoriasis Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Pediatric Psoriasis Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Pediatric Psoriasis Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Pediatric Psoriasis Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Pediatric Psoriasis Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Pediatric Psoriasis Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Pediatric Psoriasis Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Pediatric Psoriasis Players in 2022
Table 12. World Pediatric Psoriasis Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Pediatric Psoriasis Company Evaluation Quadrant
Table 14. Head Office of Key Pediatric Psoriasis Player
Table 15. Pediatric Psoriasis Market: Company Product Type Footprint
Table 16. Pediatric Psoriasis Market: Company Product Application Footprint
Table 17. Pediatric Psoriasis Mergers & Acquisitions Activity
Table 18. United States VS China Pediatric Psoriasis Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Pediatric Psoriasis Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Pediatric Psoriasis Companies, Headquarters (States, Country)
Table 21. United States Based Companies Pediatric Psoriasis Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Pediatric Psoriasis Revenue Market Share (2018-2023)
Table 23. China Based Pediatric Psoriasis Companies, Headquarters (Province, Country)
Table 24. China Based Companies Pediatric Psoriasis Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Pediatric Psoriasis Revenue Market Share (2018-2023)
Table 26. Rest of World Based Pediatric Psoriasis Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Pediatric Psoriasis Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Pediatric Psoriasis Revenue Market Share (2018-2023)
Table 29. World Pediatric Psoriasis Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Pediatric Psoriasis Market Size by Type (2018-2023) & (USD Million)
Table 31. World Pediatric Psoriasis Market Size by Type (2024-2029) & (USD Million)
Table 32. World Pediatric Psoriasis Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Pediatric Psoriasis Market Size by Application (2018-2023) & (USD Million)
Table 34. World Pediatric Psoriasis Market Size by Application (2024-2029) & (USD Million)
Table 35. Abbvie Inc Basic Information, Area Served and Competitors
Table 36. Abbvie Inc Major Business
Table 37. Abbvie Inc Pediatric Psoriasis Product and Services
Table 38. Abbvie Inc Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Abbvie Inc Recent Developments/Updates
Table 40. Abbvie Inc Competitive Strengths & Weaknesses
Table 41. Amgen Inc Basic Information, Area Served and Competitors
Table 42. Amgen Inc Major Business
Table 43. Amgen Inc Pediatric Psoriasis Product and Services
Table 44. Amgen Inc Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Amgen Inc Recent Developments/Updates
Table 46. Amgen Inc Competitive Strengths & Weaknesses
Table 47. Johnson & Johnson Basic Information, Area Served and Competitors
Table 48. Johnson & Johnson Major Business
Table 49. Johnson & Johnson Pediatric Psoriasis Product and Services
Table 50. Johnson & Johnson Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Johnson & Johnson Recent Developments/Updates
Table 52. Johnson & Johnson Competitive Strengths & Weaknesses
Table 53. Novartis Ag Basic Information, Area Served and Competitors
Table 54. Novartis Ag Major Business
Table 55. Novartis Ag Pediatric Psoriasis Product and Services
Table 56. Novartis Ag Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Novartis Ag Recent Developments/Updates
Table 58. Novartis Ag Competitive Strengths & Weaknesses
Table 59. Eli Lilly & Company Basic Information, Area Served and Competitors
Table 60. Eli Lilly & Company Major Business
Table 61. Eli Lilly & Company Pediatric Psoriasis Product and Services
Table 62. Eli Lilly & Company Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Eli Lilly & Company Recent Developments/Updates
Table 64. Eli Lilly & Company Competitive Strengths & Weaknesses
Table 65. Astrazeneca Basic Information, Area Served and Competitors
Table 66. Astrazeneca Major Business
Table 67. Astrazeneca Pediatric Psoriasis Product and Services
Table 68. Astrazeneca Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Astrazeneca Recent Developments/Updates
Table 70. Astrazeneca Competitive Strengths & Weaknesses
Table 71. Celgene Corporation Basic Information, Area Served and Competitors
Table 72. Celgene Corporation Major Business
Table 73. Celgene Corporation Pediatric Psoriasis Product and Services
Table 74. Celgene Corporation Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Celgene Corporation Recent Developments/Updates
Table 76. Celgene Corporation Competitive Strengths & Weaknesses
Table 77. Merck Basic Information, Area Served and Competitors
Table 78. Merck Major Business
Table 79. Merck Pediatric Psoriasis Product and Services
Table 80. Merck Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Merck Recent Developments/Updates
Table 82. Merck Competitive Strengths & Weaknesses
Table 83. Boehringer Ingelheim Basic Information, Area Served and Competitors
Table 84. Boehringer Ingelheim Major Business
Table 85. Boehringer Ingelheim Pediatric Psoriasis Product and Services
Table 86. Boehringer Ingelheim Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Boehringer Ingelheim Recent Developments/Updates
Table 88. Leo Pharma Basic Information, Area Served and Competitors
Table 89. Leo Pharma Major Business
Table 90. Leo Pharma Pediatric Psoriasis Product and Services
Table 91. Leo Pharma Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 92. Global Key Players of Pediatric Psoriasis Upstream (Raw Materials)
Table 93. Pediatric Psoriasis Typical Customers
Table 1. World Pediatric Psoriasis Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Pediatric Psoriasis Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Pediatric Psoriasis Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Pediatric Psoriasis Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Pediatric Psoriasis Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Pediatric Psoriasis Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Pediatric Psoriasis Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Pediatric Psoriasis Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Pediatric Psoriasis Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Pediatric Psoriasis Players in 2022
Table 12. World Pediatric Psoriasis Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Pediatric Psoriasis Company Evaluation Quadrant
Table 14. Head Office of Key Pediatric Psoriasis Player
Table 15. Pediatric Psoriasis Market: Company Product Type Footprint
Table 16. Pediatric Psoriasis Market: Company Product Application Footprint
Table 17. Pediatric Psoriasis Mergers & Acquisitions Activity
Table 18. United States VS China Pediatric Psoriasis Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Pediatric Psoriasis Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Pediatric Psoriasis Companies, Headquarters (States, Country)
Table 21. United States Based Companies Pediatric Psoriasis Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Pediatric Psoriasis Revenue Market Share (2018-2023)
Table 23. China Based Pediatric Psoriasis Companies, Headquarters (Province, Country)
Table 24. China Based Companies Pediatric Psoriasis Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Pediatric Psoriasis Revenue Market Share (2018-2023)
Table 26. Rest of World Based Pediatric Psoriasis Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Pediatric Psoriasis Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Pediatric Psoriasis Revenue Market Share (2018-2023)
Table 29. World Pediatric Psoriasis Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Pediatric Psoriasis Market Size by Type (2018-2023) & (USD Million)
Table 31. World Pediatric Psoriasis Market Size by Type (2024-2029) & (USD Million)
Table 32. World Pediatric Psoriasis Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Pediatric Psoriasis Market Size by Application (2018-2023) & (USD Million)
Table 34. World Pediatric Psoriasis Market Size by Application (2024-2029) & (USD Million)
Table 35. Abbvie Inc Basic Information, Area Served and Competitors
Table 36. Abbvie Inc Major Business
Table 37. Abbvie Inc Pediatric Psoriasis Product and Services
Table 38. Abbvie Inc Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Abbvie Inc Recent Developments/Updates
Table 40. Abbvie Inc Competitive Strengths & Weaknesses
Table 41. Amgen Inc Basic Information, Area Served and Competitors
Table 42. Amgen Inc Major Business
Table 43. Amgen Inc Pediatric Psoriasis Product and Services
Table 44. Amgen Inc Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Amgen Inc Recent Developments/Updates
Table 46. Amgen Inc Competitive Strengths & Weaknesses
Table 47. Johnson & Johnson Basic Information, Area Served and Competitors
Table 48. Johnson & Johnson Major Business
Table 49. Johnson & Johnson Pediatric Psoriasis Product and Services
Table 50. Johnson & Johnson Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Johnson & Johnson Recent Developments/Updates
Table 52. Johnson & Johnson Competitive Strengths & Weaknesses
Table 53. Novartis Ag Basic Information, Area Served and Competitors
Table 54. Novartis Ag Major Business
Table 55. Novartis Ag Pediatric Psoriasis Product and Services
Table 56. Novartis Ag Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Novartis Ag Recent Developments/Updates
Table 58. Novartis Ag Competitive Strengths & Weaknesses
Table 59. Eli Lilly & Company Basic Information, Area Served and Competitors
Table 60. Eli Lilly & Company Major Business
Table 61. Eli Lilly & Company Pediatric Psoriasis Product and Services
Table 62. Eli Lilly & Company Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Eli Lilly & Company Recent Developments/Updates
Table 64. Eli Lilly & Company Competitive Strengths & Weaknesses
Table 65. Astrazeneca Basic Information, Area Served and Competitors
Table 66. Astrazeneca Major Business
Table 67. Astrazeneca Pediatric Psoriasis Product and Services
Table 68. Astrazeneca Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Astrazeneca Recent Developments/Updates
Table 70. Astrazeneca Competitive Strengths & Weaknesses
Table 71. Celgene Corporation Basic Information, Area Served and Competitors
Table 72. Celgene Corporation Major Business
Table 73. Celgene Corporation Pediatric Psoriasis Product and Services
Table 74. Celgene Corporation Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Celgene Corporation Recent Developments/Updates
Table 76. Celgene Corporation Competitive Strengths & Weaknesses
Table 77. Merck Basic Information, Area Served and Competitors
Table 78. Merck Major Business
Table 79. Merck Pediatric Psoriasis Product and Services
Table 80. Merck Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Merck Recent Developments/Updates
Table 82. Merck Competitive Strengths & Weaknesses
Table 83. Boehringer Ingelheim Basic Information, Area Served and Competitors
Table 84. Boehringer Ingelheim Major Business
Table 85. Boehringer Ingelheim Pediatric Psoriasis Product and Services
Table 86. Boehringer Ingelheim Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Boehringer Ingelheim Recent Developments/Updates
Table 88. Leo Pharma Basic Information, Area Served and Competitors
Table 89. Leo Pharma Major Business
Table 90. Leo Pharma Pediatric Psoriasis Product and Services
Table 91. Leo Pharma Pediatric Psoriasis Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 92. Global Key Players of Pediatric Psoriasis Upstream (Raw Materials)
Table 93. Pediatric Psoriasis Typical Customers
LIST OF FIGURES
Figure 1. Pediatric Psoriasis Picture
Figure 2. World Pediatric Psoriasis Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Pediatric Psoriasis Total Market Size (2018-2029) & (USD Million)
Figure 4. World Pediatric Psoriasis Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Pediatric Psoriasis Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Pediatric Psoriasis Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Pediatric Psoriasis Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Pediatric Psoriasis Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Pediatric Psoriasis Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Pediatric Psoriasis Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Pediatric Psoriasis Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Pediatric Psoriasis Revenue (2018-2029) & (USD Million)
Figure 13. Pediatric Psoriasis Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Pediatric Psoriasis Consumption Value (2018-2029) & (USD Million)
Figure 16. World Pediatric Psoriasis Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Pediatric Psoriasis Consumption Value (2018-2029) & (USD Million)
Figure 18. China Pediatric Psoriasis Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Pediatric Psoriasis Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Pediatric Psoriasis Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Pediatric Psoriasis Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Pediatric Psoriasis Consumption Value (2018-2029) & (USD Million)
Figure 23. India Pediatric Psoriasis Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Pediatric Psoriasis by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Pediatric Psoriasis Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Pediatric Psoriasis Markets in 2022
Figure 27. United States VS China: Pediatric Psoriasis Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Pediatric Psoriasis Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Pediatric Psoriasis Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Pediatric Psoriasis Market Size Market Share by Type in 2022
Figure 31. Oral
Figure 32. Injection
Figure 33. Others
Figure 34. World Pediatric Psoriasis Market Size Market Share by Type (2018-2029)
Figure 35. World Pediatric Psoriasis Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Pediatric Psoriasis Market Size Market Share by Application in 2022
Figure 37. Hospital
Figure 38. Clinic
Figure 39. Others
Figure 40. Pediatric Psoriasis Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Figure 1. Pediatric Psoriasis Picture
Figure 2. World Pediatric Psoriasis Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Pediatric Psoriasis Total Market Size (2018-2029) & (USD Million)
Figure 4. World Pediatric Psoriasis Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Pediatric Psoriasis Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Pediatric Psoriasis Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Pediatric Psoriasis Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Pediatric Psoriasis Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Pediatric Psoriasis Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Pediatric Psoriasis Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Pediatric Psoriasis Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Pediatric Psoriasis Revenue (2018-2029) & (USD Million)
Figure 13. Pediatric Psoriasis Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Pediatric Psoriasis Consumption Value (2018-2029) & (USD Million)
Figure 16. World Pediatric Psoriasis Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Pediatric Psoriasis Consumption Value (2018-2029) & (USD Million)
Figure 18. China Pediatric Psoriasis Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Pediatric Psoriasis Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Pediatric Psoriasis Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Pediatric Psoriasis Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Pediatric Psoriasis Consumption Value (2018-2029) & (USD Million)
Figure 23. India Pediatric Psoriasis Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Pediatric Psoriasis by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Pediatric Psoriasis Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Pediatric Psoriasis Markets in 2022
Figure 27. United States VS China: Pediatric Psoriasis Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Pediatric Psoriasis Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Pediatric Psoriasis Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Pediatric Psoriasis Market Size Market Share by Type in 2022
Figure 31. Oral
Figure 32. Injection
Figure 33. Others
Figure 34. World Pediatric Psoriasis Market Size Market Share by Type (2018-2029)
Figure 35. World Pediatric Psoriasis Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Pediatric Psoriasis Market Size Market Share by Application in 2022
Figure 37. Hospital
Figure 38. Clinic
Figure 39. Others
Figure 40. Pediatric Psoriasis Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
